Certara (NASDAQ:CERT) Downgraded by Wall Street Zen to Hold

Wall Street Zen downgraded shares of Certara (NASDAQ:CERT) from a buy rating to a hold rating in a report published on Sunday morning.

CERT has been the topic of several other reports. Barclays dropped their price objective on shares of Certara from $16.00 to $14.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. BMO Capital Markets initiated coverage on shares of Certara in a report on Thursday. They issued a “market perform” rating and a $9.00 price target on the stock. UBS Group reduced their price objective on Certara from $17.50 to $15.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Zacks Research raised Certara from a “strong sell” rating to a “hold” rating in a research report on Friday, September 5th. Finally, KeyCorp upped their price objective on Certara from $15.00 to $16.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Certara presently has a consensus rating of “Hold” and an average target price of $14.67.

Certara Price Performance

Shares of NASDAQ CERT opened at $8.33 on Friday. Certara has a fifty-two week low of $8.13 and a fifty-two week high of $15.69. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of 119.00 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.09 and a quick ratio of 2.09. The business has a 50-day moving average of $11.56 and a 200-day moving average of $11.28.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. Certara had a net margin of 2.62% and a return on equity of 5.18%. The company had revenue of $104.62 million during the quarter, compared to the consensus estimate of $104.53 million. During the same quarter last year, the firm posted $0.13 EPS. Certara has set its FY 2025 guidance at 0.450-0.470 EPS. As a group, sell-side analysts predict that Certara will post 0.28 earnings per share for the current fiscal year.

Insider Transactions at Certara

In other news, insider Leif E. Pedersen sold 51,224 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $10.92, for a total value of $559,366.08. Following the transaction, the insider owned 73,979 shares in the company, valued at $807,850.68. This trade represents a 40.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.33% of the company’s stock.

Institutional Trading of Certara

Several institutional investors have recently made changes to their positions in CERT. Private Advisor Group LLC boosted its holdings in Certara by 4.0% during the first quarter. Private Advisor Group LLC now owns 24,517 shares of the company’s stock worth $243,000 after purchasing an additional 949 shares during the last quarter. Associated Banc Corp grew its holdings in shares of Certara by 9.7% in the third quarter. Associated Banc Corp now owns 11,920 shares of the company’s stock valued at $146,000 after acquiring an additional 1,051 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its position in shares of Certara by 2.5% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 45,745 shares of the company’s stock valued at $535,000 after acquiring an additional 1,136 shares during the last quarter. Versant Capital Management Inc lifted its holdings in Certara by 66.7% during the third quarter. Versant Capital Management Inc now owns 2,881 shares of the company’s stock worth $35,000 after acquiring an additional 1,153 shares during the period. Finally, Osaic Holdings Inc. lifted its holdings in Certara by 50.7% during the second quarter. Osaic Holdings Inc. now owns 3,491 shares of the company’s stock worth $41,000 after acquiring an additional 1,175 shares during the period. Institutional investors own 73.96% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.